COVID-19 PCR Testing: Choose The Option That's Right For You
About our COVID-19 PCR Test
Detects Known Variants
Our PCR Test detects known variants, including Delta and Omicron
PCR tests are considered a gold standard by the CDC* for diagnosing COVID-19 because of their sensitivity and specificity
60M+ PCR Tests Performed
Labcorp has performed over 60 million COVID-19 tests since March 2020
Trusted by Doctors
Our PCR test is the same test used by doctors & hospitals to detect COVID-19.
Learn More About COVID-19
Test Comparison: Understanding the Different COVID-19 Tests
Do you know what a PCR test is? What happens to those nasal swabs after they’re taken? And what does it mean to have antibodies? Learn the answers to these common questions and more, so you can make the right decisions for your health and safety.
Treatments and Vaccines
What COVID-19 treatments are available?
Though patients can recover from COVID-19 on their own, some patients are at risk for becoming seriously ill. There are now treatments available to assist with COVID-19 recovery, such as monoclonal antibodies, oral antivirals, or hospital treatments like antiviral drugs or convalescent plasma. Talk to your doctor and visit the HHS website for more information.
Learn more about treatment options
*The information above is solely for educational purposes and is provided by Merck & Co., Inc. Labcorp does not endorse or recommend treatments. Please consult a healthcare professional.
Labcorp Supports COVID-19 Blood Plasma Donation
We are proud to be part of The Fight Is In Us coalition to increase donations of blood plasma with COVID-19 antibodies. Blood plasma is being evaluated as a possible treatment for patients with an active COVID-19 infection. Public health authorities have asked for help with expanding the population of potential plasma donors. If you have recovered from COVID-19, you can test for antibodies by talking with your healthcare provider or by requesting one through Labcorp.
Vaccination has been shown to be very effective at preventing severe illness and hospitalization for COVID-19. Labcorp has worked with several companies for their COVID-19 vaccination clinical trials. The more people who are vaccinated, the more likely we are as a society to move beyond this current pandemic.
Frequently Asked Questions
You are eligible for $0 upfront cost if you are insured and meet one or more of the following clinical guidelines for COVID-19 testing:
- You are experiencing mild symptoms
- You have been exposed to someone with COVID-19
- You live or work in a congregate setting
- You have been asked to get tested by a healthcare professional, contact investigator, or public health department.
If you do not meet clinical guidelines but would like to get tested for peace of mind, travel, screening for work or school, or other activities, you can pay out of pocket.
If you are uninsured please visit HRSA.gov for more information, or visit Labcorp’s COVID-19 Resource center for other testing options.
The Labcorp OnDemand COVID-19 test is an NAAT test, also known as a PCR test. PCR tests are considered the gold standard by the CDC for diagnosing COVID-19 because of their sensitiviy and specificity.
Currently the average time to deliver results is 1-2 days from when the sample is received at the lab. Our labs process samples seven days a week. Check with your local FedEx for pick up and drop off schedules.
Sample collection is quick and easy. The kit includes a short nasal swab that is inserted into the lower nostril, reducing the discomfort associated with longer nasopharyngeal swabs.
Check out our COVID-19 FAQs for more information.
Labcorp’s COVID-19 PCR test has not been FDA cleared or approved, has been authorized by FDA under an Emergency Use Authorization (EUA), and has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.